BPA for tamc for human breastmilk fortifiers

Ended Blanket Purchase Agreement Awarded Last action

Contract number
W81K0217A0025
Awardee
Awarding agency
Task orders
12 $1,008,668 obligated

Award facts

Opportunity
Combined order value
$1,008,668 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 40% used
$2,500,000.00
Maximum order
$150,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

Prolacta Bioscience, Inc. was awarded a single award blanket purchase agreement by the Department of the Army Medical Command to provide human breastmilk fortifiers and related products. The BPA has a potential value of $2.5 million and period of performance from October 2017 through September 2022. Prolacta Bioscience is a manufacturer of goods specializing in neonatal nutrition products derived from human breastmilk.

Under the BPA, Prolacta Bioscience has received multiple firm fixed price calls to supply its specialized milk-based items to various military medical treatment facilities. Notable calls include provision of breastmilk and fortification products to the Tripler Army Medical Center in Hawaii from June 2022 to September 2022 for $18,515.94, and products for extremely premature infants to the Bassett, California facility from September 2022 to September 2022 for $18,625.79. Collectively, the multiple calls against this BPA from 2019 through the present have totaled over $3.7 million to provide nutritional therapies and support for at-risk newborns treated at Defense Health Agency and Department of Army Medical Command locations.

Task orders

Show all 12

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · 889 action - BPA for human breastmilk fortifiers. $0
Other Administrative Action P00002 · Requirement is for human breastmilk fortifiers. Modification is to increase the call limit from $150,000.00 to $250,000.00. $0
Supplemental Agreement for work within scope P00001 · Requirement is for human breastmilk fortifiers. Modification is to convert the BPA to a regional BPA, increase the master dollar limit and include the updated… $0
Original award $0

Quick answers

Who was awarded contract W81K0217A0025?

W81K0217A0025 was awarded to Prolacta Bioscience, Inc. by Medical Command (Department of the Army) on October 1, 2017.

How much is contract W81K0217A0025 worth?

Orders under W81K0217A0025 have obligated $1,008,668. W81K0217A0025's own ceiling is $2,500,000. A single order can be worth up to $150,000.

How many orders have been placed under contract W81K0217A0025?

12 orders have been placed under W81K0217A0025, the latest on September 26, 2022.

Who can order from contract W81K0217A0025?

W81K0217A0025 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV